Back to results
US 2026/0176313 A1Published application
Tgf-beta-1 vaccine
OwnerMads Hald ANDERSENinventor
Life of this patent
Estimating the term…
Abstract
The present invention relates to novel polypeptides, which are derived from transforming growth factor beta 1 (TGFβ1; TGFb-1) as well as polynucleotides encoding such polypeptides and compositions comprising such peptides. The present invention is further concerned with ways to increase the selectivity of the immune response to TGFb-1. The invention also concerns uses, and methods of using, said polypeptides, polynucleotides, and compositions.
Claims24
A polypeptide which is an immunogenic fragment of human transforming growth factor 1 (TGFb-1) and which comprises or consists of a sequence of at least 8 consecutive amino acids of SEQ ID NO:
- 5.
Dependencies are inferred from the claim text.